Liver Cancer Awareness Month – October 2023
Every October, we stand united for #LiverCancerAwarenessMonth, and EASL is proud to support this vital campaign. This month is a significant opportunity to raise awareness, educate, and advocate for liver health on a global scale. It serves as a reminder…
Tribute to Prof. Gustav Paumgartner (1933-2023)
EASL mourns the loss of Gustav Paumgartner, a luminary in the field of hepatology and a true visionary. Born on November 23, 1933, Gustav's contributions to liver research and patient care have left an indelible mark on our community. Gustav’s…
Call for Applications for Position of Editor-in-Chief, Journal of Hepatology
The Journal of Hepatology, EASL's flagships journal, has been in circulation since 1985. With an Impact Factor of 25.7 as of 2022, it stands as the foremost hepatology-exclusive journal. Journal of Hepatology is an innovative Journal publishing articles on global…
Meet our new Young Investigators Task Force Members
Why did you apply for the EASL YIs Task Force? As a passionate young researcher in the field of hepatology, I believe that the EASL is the perfect platform to further my professional development and contribute to the advancement of…
Join the Nurses & AHPs Task Force
To reach improved treatment and support, nurses and allied health professionals are increasingly working at the forefront of healthcare. They play a key role in supporting patients in many countries, while greatly improving the lives of the patients living with…
Join the EASL Scientific Committee
Join the EASL Scientific Committee EASL is now calling for applications for one new member to join the Scientific Committee. The term for these members is from October 2023 to October 2026.
Tribute to Prof. Peter Ferenci (1948-2023)
Dear colleagues and friends: We have to share the sad news that Peter Ferenci has passed away on 11 April 2023 just a few weeks before his 75th birthday. He recently celebrated his 50 years anniversary at the Medical University…
Diagnosis of fatty liver in children should occur in parallel to investigation for other causes of liver disease
The European Association for the Study of the Liver (EASL) and the Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) have issued a joint statement on metabolic dysfunction-associated fatty liver disease (MAFLD), now available for consultation. This statement provides clear…